StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Monday. The firm set a “hold” rating on the stock.

Milestone Scientific Trading Down 8.3 %

NYSE:MLSS opened at $0.99 on Monday. The company has a market cap of $77.11 million, a PE ratio of -14.14 and a beta of 1.41. The company has a 50 day simple moving average of $1.11 and a two-hundred day simple moving average of $0.96. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Carnegie Investment Counsel boosted its holdings in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the last quarter. Geode Capital Management LLC raised its position in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific during the 3rd quarter worth $48,000. Renaissance Technologies LLC grew its position in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after acquiring an additional 53,198 shares during the period. Finally, World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific in the 3rd quarter worth $91,000. 5.79% of the stock is owned by hedge funds and other institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.